Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Pharma
Shionogi's antiviral comes up short in global COVID-19 trial
Shionogi's antiviral ensitrelvir missed the mark in a late-stage COVID-19 trial, putting a damper on U.S. approval prospects for the drug.
Fraiser Kansteiner
May 13, 2024 10:48am
Merck's Keytruda misses the mark in endometrial cancer study
May 9, 2024 10:55am
Argenx gears up to launch Vyvgart in next potential indication
Apr 16, 2024 2:24pm
Pfizer plots new RSV filing with positive Abrysvo data in adults
Apr 9, 2024 6:45am
FDA revokes approval of Oncopeptides' Pepaxto
Feb 23, 2024 11:10am
Theravance's COPD med Yupelri flunks head-to-head study
Jan 5, 2024 10:14am